About Q-Med
Q-Med is a Healthcare company based in Uppsala (Sweden) founded in 1987 by Manuel Aguero, and was acquired by Galderma in December 2011. Medical implants based on Non-Animal Stabilized Hyaluronic Acid for esthetics, orthopedics, urogynecology, and cell therapy. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices.
Company details
Q-Med engages in the development, manufacture, marketing, and sale of medical implants for aesthetic and medical use. The companys products are based on its patented technology, NASHA, which is used to produce stabilized non-animal hyaluronic acid. Its products include (1) Restylane products for filling out wrinkles and contouring lips (2) Macrolane VRF for body shaping (3) Deflux, which is used in the treatment of vesicoureteral reflux in children (4) Durolane for the treatment of osteoarthritis of the knee and hip joints (5) Solesta for the treatment of fecal incontinence. Q-Med sells its products through subsidiaries or distributors worldwide. In 2007 Q-Med acquired Ox-thera for approximately 30M. Q-Med was acquired by Galderma for 1.8B in 2011.
Investors in Q-Med
Q-Med has secured backing from 1 investor. Prominent investors backing the company include Galderma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dermatological products are manufactured to treat various skin conditions. | 1981 | galderma.com | Zug, Switzerland |
Investor details for Q-Med
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Q-Med
1 people are tracked at Q-Med (1 in leadership).
| Name | Role | Group |
|---|---|---|
Manuel Aguero | Co-Founder & President | Leadership |
Complete people profiles for Q-Med
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Q-Med
2 dated milestones of Q-Med across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Q-Med is founded.
- Exit Acquired by Galderma.
Web traffic of Q-Med
Websites that share an audience with Q-Med (q-med.com).
Websites whose visitors overlap most with Q-Med. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
restylane.com | restylane.com | 100% | #14,825,159 | – | |
medela.se | medela.se | 99% | – | ||
eventasjukvard.se | eventasjukvard.se | 99% | – | ||
maxgrepp.se | maxgrepp.se | 99% | – | ||
sear.se | sear.se | 99% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Q-Med
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Q-Med
Q-Med was founded in 1987.
Q-Med is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Q-Med engages in the development, manufacture, marketing, and sale of medical implants for aesthetic and medical use. The companys products are based on its patented technology, NASHA, which is used to produce stabilized non-animal hyaluronic acid. Its products include (1) Restylane products for filling out wrinkles and contouring lips (2) Macrolane VRF for body shaping (3) Deflux, which is used in the treatment of vesicoureteral reflux in children (4) Durolane for the treatment of osteoarthritis of the knee and hip joints (5) Solesta for the treatment of fecal incontinence. Q-Med sells its products through subsidiaries or distributors worldwide. In 2007 Q-Med acquired Ox-thera for approximately 30M. Q-Med was acquired by Galderma for 1.8B in 2011.
Q-Med has 1 investor. Key investors include Galderma.
Yes. Q-Med was acquired by Galderma in December 2011.